DANAHER CORPORATION
Last · NYSE$224.74+1.90 (+0.85%)close · yahoo · 14h ago
Market cap$157.99B703.0M sh
P/E · TTM40.1fwd 24.2 · eps 5.61
Beta0.80vs S&P 500
Div yield0.65%annual · TTM
52w range
$160.93$242.80
Volume3.0Msession
| Revenue | $24.8B |
|---|---|
| Operating income | $4.8B |
| Net income | $3.7B |
| Free cash flow | $5.3B |
| Operating margin | 19.2% |
| Net margin | 14.9% |
| Return on equity | 7.0% |
| Period | TTM 2026-03-27 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-02-24
- Earnings Decline
- Higher Leverage
- Cash Flow
- Refinancing Risk
- Working Capital
- Share Repurchase
- Life Sciences
Red flags
- Continuing-operations net earnings declined to $3.6 billion in 2025 from $3.9 billion in 2024 and $4.2 billion in 2023; diluted EPS fell to $5.03 from $5.29 and $5.65.
- Total debt rose to $18.4 billion from $16.0 billion, while long-term debt increased to $18.4 billion from $15.5 billion; approximately $3.5 billion of borrowings are classified as long term based on expected refinancing capacity.
- Operating cash flow fell $272 million, or 4%, to $6.4 billion, while inventories increased to $2.49 billion from $2.33 billion.
- The company had approximately $1.3 billion of legally binding purchase obligations at December 31, 2025, with most expected to be settled during 2026.
- 2025 share repurchases consumed $3.09 billion and dividends consumed $878 million despite lower earnings and higher debt; the company expects an additional $24 million of excise tax related to those repurchases in 2026.
Upcoming earnings
2:30 PM UTC+2
Period
Sep 2026
Est. EPS
$1.92
Est. revenue
6.6B
Earnings transcripts
Documents
FormReporting forFiledFlags